SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-083361
Filing Date
2010-09-02
Accepted
2010-09-02 14:57:51
Documents
4
Period of Report
2010-08-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w79728e8vk.htm 8-K 13299
2 EX-99.1 w79728exv99w1.htm EX-99.1 5928
3 GRAPHIC w79728w7972802.gif GRAPHIC 2696
4 GRAPHIC w79728w7972800.gif GRAPHIC 4232
  Complete submission text file 0000950123-10-083361.txt   30703
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 101054752
SIC: 2834 Pharmaceutical Preparations